References
1. Hasperhoven GF, Al-Nasiry S, Bekker V, et al. Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset Group B streptococcal disease: a systematic review and meta-analysis. BJOG: An International Journal of Obstetrics & Gynaecology 2020;n/a(n/a) doi: 10.1111/1471-0528.16085
2. Seedat F, Geppert J, Stinton C, et al. Universal antenatal screening for group B streptococcus may cause more harm than good. 2019;364:l463. doi: 10.1136/bmj.l463 %J BMJ
3. Bevan D, White A, Marshall J, et al. Modelling the effect of the introduction of antenatal screening for group B Streptococcus (GBS) carriage in the UK. BMJ open 2019;9(3):e024324-e24. doi: 10.1136/bmjopen-2018-024324
4. National Institute for Health Research. The clinical and cost-effectiveness of testing for Group B Streptococcus: a cluster randomised trial with economic and acceptability evaluations (GBS3). United Kingdom: National Institute for Health Research; 2019 [Available from: https://fundingawards.nihr.ac.uk/award/17/86/06 accessed 14 February 2020.